RENAL PROLIFERATIVE AND PHENOTYPIC CHANGES IN RATS WITH 2-KIDNEY, ONE-CLIP GOLDBLATT HYPERTENSION

被引:79
作者
ENG, E
VENIANT, M
FLOEGE, J
FINGERLE, J
ALPERS, CE
MENARD, J
CLOZEL, JP
JOHNSON, RJ
机构
[1] Division of Nephrology, Department of Medicine, Department of Pathology, University of Washington, Seattle, WA
关键词
ANGIOTENSIN II; GOLDBLATT HYPERTENSION; RAT; KIDNEY;
D O I
10.1093/ajh/7.2.177
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Angiotensin II (AII) is a vasoconstrictive peptide with hypertrophic and mitogenic effects on many cell types. Previous studies have shown that in vivo administration of AII in rats results in proliferation of, and phenotypic changes in, many renal cell populations, but in doses also causing hypertension. Thus, it was not possible to differentiate nonhemodynamic from hypertensive effects of AII. Therefore, we studied rats with renin-dependent, AII-mediated hypertension (the two-kidney, one-clip Goldblatt model; mean systolic blood pressure 238 +/- 48 v 140 +/- 6 mm Hg in sham-operated controls). The unclipped kidneys, which were exposed to high blood pressure, developed significant glomerular and tubulointerstitial injury, tubulointerstitial cell proliferation, dense focal interstitial monocyte-macrophage influx, increased deposition of types I and IV collagen, as well as increased cellular expression of desmin and actin, in tubulointerstitial areas when examined at 11 weeks. In contrast, clipped kidneys, protected from hypertension but with high local renin expression, had minimal abnormalities. These studies suggest that in this model increased renin, and presumably AII, does not mediate significant proliferative or phenotypic changes in the kidney in the absence of hypertension at 11 weeks.
引用
收藏
页码:177 / 185
页数:9
相关论文
共 45 条
  • [1] Hall J.E., Guyton A.C., Salgado H.C., Et al., Renal hemo-dynamics in acute and chronic angiotensin II hypertension, Am J Physiol, 235, pp. F174-F179, (1978)
  • [2] Zimmerman B.G., Sybertz E.J., Wong P.C., Interaction between sympathetic and renin-angiotensin system, J Hypertens, 2, pp. 581-587, (1984)
  • [3] Koletsky S., Rivera-Velez J.M., Pritchard W.H., Production of hypertension and vascular disease by angiotensin, Arch Pathol, 82, pp. 99-106, (1966)
  • [4] Wilson C., Byrom F.B., Lond M.D., Renal changes in malignant hypertension, Lancet, 1, pp. 136-139, (1939)
  • [5] Wilson C., Byrom F.B., The vicious circle in Bright's disease. Experimental evidence from the hypertensive rat, Q J Med, 10, pp. 65-96, (1940)
  • [6] Johnson R.J., Alpers C.E., Yoshimura A., Et al., Renal injury from angiotensin II mediated hypertension, Hypertension, 19, pp. 464-474, (1992)
  • [7] Schelling P., Gantin D., Speck G., Fischer H., Effects of angiotensin II and angiotensin II antagonist saralasin on cell growth and renin in 3T3 and SV 3T3 cells, J Cell Physiol, 98, pp. 503-514, (1979)
  • [8] Geisterfer A., Peach M.J., Owens G.K., Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells, Circ Res, 62, pp. 749-756, (1988)
  • [9] Wolf G., Neilson E.G., Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells, Am J Physiol, 259, pp. F768-F777, (1990)
  • [10] Ray P.E., Aguilera G., Kopp J.B., Et al., Angiotensin II receptor-mediated proliferation of cultured human fetal mesangial cells, Kidney Int, 40, pp. 764-771, (1991)